Scopia Capital Management LP Horizon Therapeutics Public LTD CO Transaction History

Scopia Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $26.2 Million - $37.9 Million	-473,575 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $23.9 Million - $45.1 Million	-790,827 Reduced 62.55%	473,575 $26.3 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $31.4 Million - $48.7 Million	-1,263,054 Reduced 49.97%	1,264,402 $37.5 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $43.1 Million - $62.1 Million	-1,694,129 Reduced 40.13%	2,527,456 $91.5 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $1.54 Million - $1.87 Million	-66,902 Reduced 1.56%	4,221,585 $115 Million

Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $97.8 Million - $122 Million	4,288,487 New	4,288,487 $103 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Scopia Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Scopia Capital Management LP with notifications on news.